Active Ingredient(s): Carboprost Tromethamine
FDA Approved: * January 9, 1979
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Hemabate Overview

Carboprost (INN, trade names for the tromethamine salts Hemabate, Tham) is a synthetic prostaglandin analogue of PGF2α (specifically, it is 15-methyl-PGF2α) with oxytocic properties. Carboprost main use is in the obstetrical emergency of postpartum hemorrhage which reduces postpartum bleeding during these circumstances. Contents 1 Indication 2 Contraindication 3 Precautions 4 Adverse Effects 5 Storage and Availability 6 Synthesis 7 See also 8 References 9 Further reading 10 Exter...

Read more Hemabate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Carboprost

Recent Hemabate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Carboprost Tromethamine
  • Injection: 0.25mg/ml, 250mcg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Hemabate: (1 result)

Sorted by National Drug Code
  • 0009-0856 Hemabate 250 ug/ml Intramuscular Injection, Solution by Pharmacia and Upjohn Company

Other drugs which contain Carboprost Tromethamine or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA